Breaking News Bar

Business News and Information

Aerie Pharmaceuticals receives second FDA approval for glaucoma drug

Aerie Pharmaceuticals – less than a year after launching their first glaucoma drug – has received FDA approval for its second.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear